Page last updated: 2024-08-18

cyclohexanol and Hot Flashes

cyclohexanol has been researched along with Hot Flashes in 65 studies

Research

Studies (65)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (3.08)	18.2507
2000's	31 (47.69)	29.6817
2010's	32 (49.23)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hao, Y; Sun, Z; Zhang, M	1
Anderson, GL; Caan, B; Carpenter, JS; Cohen, LS; Ensrud, KE; Freeman, EW; Guthrie, KA; Joffe, H; Kroenke, K; Lacroix, AZ; Larson, JC; Newton, KM; Reed, SD; Sammel, MD; Sherman, S; Sternfeld, B	1
Fujii, T; Kobayashi, D; Natori, A; Okajima, Y; Yamaguchi, N	1
Adams, PT; Frizzell, B; Griffin, L; Lesser, GJ; Moose, D; Naughton, M; Radford, JE; Shaw, EG; Tomlinson, WV; Vitolins, MZ; Vuky, J	1
Cavanagh, J; Ferrell, W; Krishnadas, R; Lumsden, MA; Nicol, A; Pimlott, SL; Sassarini, J	1
Anderson, GL; Caan, B; Carpenter, JS; Cohen, L; Ensrud, KE; Freeman, EW; Guthrie, KA; Hunt, J; Joffe, H; LaCroix, AZ; Larson, JC; Manson, JE; Newton, KM; Reed, SD; Rexrode, KM; Shifren, J; Sternfeld, B	1
Cohen, L; Freeman, EW; Guthrie, KA; Joffe, H; LaCroix, AZ; Larson, JC; Manson, JE; Mitchell, CM; Newton, KM; Reed, SD; Shifren, JL	1
Berhan, A; Berhan, Y	1
Gallagher, JC; Tella, SH	1
Caan, B; Carpenter, JS; Ensrud, KE; Freeman, EW; Guthrie, KA; Hohensee, C; Joffe, H; LaCroix, AZ; Landis, CA; Manson, J; Newton, KM; Otte, J; Reed, SD; Shifren, JL; Sternfeld, B; Woods, NF	1
Li, D; Lun, YZ; Zhou, SS	1
Cohen, L; Joffe, H; LaCroix, AZ	1
Anderson, GL; Caan, B; Carpenter, JS; Cohen, LS; Ensrud, KE; Freeman, EW; Guthrie, KA; Joffe, H; LaCroix, AZ; Larson, JC; Manson, JE; Newton, KM; Reed, SD; Rexrode, K; Skaar, TC; Sternfeld, B	1
Buijs, C; de Jong, RS; de Vries, EG; Marike Boezen, H; Maurer, JM; Mom, CH; Mourits, MJ; Nieboer, P; Willemse, PH; Wymenga, AN	1
Flockhart, DA; Hayes, DF; Henry, NL; Riba, M; Stearns, V	1
Archer, DF; Constantine, GD; Olivier, S; Pickar, JH; Seidman, L	1
Archer, DF; Constantine, GD; Dupont, CM; Olivier, S; Pickar, JH	1
Barton, DL	1
Bouchard, P; Irani, J; Mottet, N; Oba, R; Salomon, L	1
Ball, RM; Jakary, S; Kohn, B; Levine, RA; Nunez, R; Pegg, J; Peterson, E; Pocock, JR; Rodriguez, AI; Walker, EM	1
Archer, DF	1
Levine, MN	1
Crystal, SC; Grosberg, BM; Hutchinson, S; Robbins, MS	1
Doherty, DA; Emery, LI; Gregson, J; Hickey, M; Saunders, CM	1
Bordeleau, L; Ennis, M; Goodwin, PJ; Haq, R; Jugovic, O; Loprinzi, CL; Pritchard, KI; Warr, D	1
Adriaansz, S; Beijnen, JH; Boekhout, AH; Dalesio, OB; Foekema-Töns, JH; Nuijen, B; Schellens, JH; Sprangers, S; van den Bosch, J; Vincent, AD	1
Barton, DL; Loprinzi, CL; Qin, R	1
Astl, D; Ausmanas, MK; Cheng, RF; Gallagher, JC; Seljan, P; Strzinek, RA	1
Bao, W; Bouchard, P; Cheng, RJ; Constantine, G; de Villiers, TJ; Panay, N; Vincendon, P	1
Guttuso, T	1
Girbig, D; Igl, BW; Lehmann, T; Obendorf, M; Patchev, VK; Prelle, K	1
Archer, DF; Bao, W; Cheng, RJ; Constantine, G; Dupont, C; Pickar, JH; Racketa, J	1
Cheng, RF; Constantine, G; Hwang, E; Pinkerton, JV	1
Archer, DF; Cheng, RF; Guico-Pabia, CJ; Hwang, E; Pinkerton, JV	2
Neher, JO; Sarkissian, A; Singh, R; St Anna, L	1
Gibson-Helm, M; Sayakhot, P; Teede, HJ; Vincent, A	1
Sleijfer, DT; Wymenga, AN	1
Bydder, SA; Spry, NA	1
Ansani, NT; Schober, CE	1
Goetz, MP; Loprinzi, CL	1
Barton, D; Loprinzi, CL	1
Stearns, V	1
Evans, ML; Jaffe, RB; McClish, K; Morgan, KS; Pritts, E; Vittinghoff, E	1
Bannink, M; Bontenbal, M; Seynaeve, C; van Gool, AR	1
Aronow, WS; Beck, G; Ness, J	1
Biglia, N; Cacciari, F; Kubatzki, F; Maggiorotto, F; Ponzone, R; Roagna, R; Sismondi, P; Torta, R	1
Adjei, AA; Atherton, P; Barton, DL; Carpenter, LA; Collins, M; Fitch, TR; Flynn, PJ; Loprinzi, CL; Mincey, BA; Rummans, TA; Shanafelt, TD; Sloan, JA	1
Beck, MG; Digmann, RR; Phillips, BB	1
Barton, D; Bearden, JD; Dakhil, SR; Fitch, TR; Kugler, JW; Levitt, R; Loprinzi, CL; Mailliard, JA; Nikcevich, DA; Sloan, JA; Tschetter, LK	1
Albertazzi, P	1
Azzouz, F; Carpenter, JS; Elam, JL; Johns, S; Johnson, CS; Monahan, PO; Shelton, RC; Storniolo, AM	1
Kaufmann, M; Loibl, S; Mehta, KM; Schwedler, K; Strohmeier, R; von Minckwitz, G	1
Baum, NH; Torti, DC	1
Constantine, G; Gass, M; Olivier, S; Speroff, L	1
Dumesic, DA; Fonseca, R; Loprinzi, CL; Novotny, PJ; Perez, EA; Pisansky, TM; Quella, SK; Rummans, TA; Sloan, JA; Zahasky, KM	1
Antolak, SJ; Burch, PA; Loprinzi, CL; Novotny, P; Perez, EA; Pisansky, TM; Quella, SK; Sloan, J	1
Gottlieb, N	1
Barlow, DH	1
Barton, DL; Christensen, BJ; Dakhil, SR; Kugler, JW; LaVasseur, BI; Loprinzi, CL; Mailliard, JA; Novotny, PJ; Rodger, K; Rummans, TA; Sloan, JA	1
Grady-Weliky, TA; Hartmann, DM	1
Dvorak, SR	1

Reviews

14 review(s) available for cyclohexanol and Hot Flashes

Article	Year
Efficacy and safety of desvenlafaxine treatment for hot flashes associated with menopause: a meta-analysis of randomized controlled trials. Gynecologic and obstetric investigation, 2013, Volume: 75, Issue:4 Topics: Antidepressive Agents; Cyclohexanols; Desvenlafaxine Succinate; Female; Hot Flashes; Humans; Menopause; Middle Aged; Randomized Controlled Trials as Topic	2013
The efficacy of nonestrogenic therapy to hot flashes in cancer patients under hormone manipulation therapy: a systematic review and meta-analysis. Journal of cancer research and clinical oncology, 2013, Volume: 139, Issue:10 Topics: Amines; Antineoplastic Agents, Hormonal; Cyclohexanecarboxylic Acids; Cyclohexanols; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Neoplasms, Hormone-Dependent; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride	2013
Is desvenlafaxine effective and safe in the treatment of menopausal vasomotor symptoms? A meta-analysis and meta-regression of randomized double-blind controlled studies. Ethiopian journal of health sciences, 2014, Volume: 24, Issue:3 Topics: Chemotherapy, Adjuvant; Cyclohexanols; Desvenlafaxine Succinate; Double-Blind Method; Female; Hot Flashes; Humans; Menopause; Neurotransmitter Uptake Inhibitors; Randomized Controlled Trials as Topic; Regression Analysis	2014
Efficacy of desvenlafaxine succinate for menopausal hot flashes. Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:16 Topics: Affect; Cyclohexanols; Desvenlafaxine Succinate; Female; Hot Flashes; Humans; Menopause; Quality of Life; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sleep	2014
Drug interactions and pharmacogenomics in the treatment of breast cancer and depression. The American journal of psychiatry, 2008, Volume: 165, Issue:10 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Antineoplastic Agents, Hormonal; Biotransformation; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Delayed-Action Preparations; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Genotype; Hot Flashes; Humans; Middle Aged; Pharmacogenetics; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Treatment Outcome; Venlafaxine Hydrochloride	2008
Effective and clinically meaningful non-hormonal hot flash therapies. Maturitas, 2012, Volume: 72, Issue:1 Topics: Actaea; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Cyclohexanols; Desvenlafaxine Succinate; Estrogen Replacement Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Glycine max; Hot Flashes; Humans; Isoflavones; Mandelic Acids; Menopause; Phytotherapy; Plant Extracts	2012
Clinical Inquiry: Do venlafaxine and gabapentin control hot flashes in women with a history of breast cancer? The Journal of family practice, 2012, Volume: 61, Issue:12 Topics: Amines; Anti-Anxiety Agents; Breast Neoplasms; Constipation; Cyclohexanecarboxylic Acids; Cyclohexanols; Dizziness; Dose-Response Relationship, Drug; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Off-Label Use; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride	2012
Management of hot flushes in breast cancer patients. Acta oncologica (Stockholm, Sweden), 2002, Volume: 41, Issue:3 Topics: Adrenergic alpha-Agonists; Breast Neoplasms; Cyclohexanols; Female; Hot Flashes; Humans; Megestrol Acetate; Venlafaxine Hydrochloride	2002
A hot flash on tamoxifen metabolism. Journal of the National Cancer Institute, 2003, Dec-03, Volume: 95, Issue:23 Topics: Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cyclohexanols; Cytochrome P-450 CYP2D6; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Fluoxetine; Hot Flashes; Humans; Hydroxylation; Paroxetine; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen; Venlafaxine Hydrochloride	2003
Making sense of the evidence regarding nonhormonal treatments for hot flashes. Clinical journal of oncology nursing, 2004, Volume: 8, Issue:1 Topics: Acetates; Activities of Daily Living; Algorithms; Amines; Cyclohexanecarboxylic Acids; Cyclohexanols; Decision Trees; Drug Monitoring; Drug Therapy, Combination; Evidence-Based Medicine; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Menopause; Middle Aged; Nursing Assessment; Patient Selection; Quality of Life; Selective Serotonin Reuptake Inhibitors; Self Care; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride	2004
Management of hot flashes in breast cancer survivors and men with prostate cancer. Current oncology reports, 2004, Volume: 6, Issue:4 Topics: Amines; Anti-Anxiety Agents; Breast Neoplasms; Complementary Therapies; Contraceptives, Oral, Synthetic; Cyclohexanecarboxylic Acids; Cyclohexanols; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Male; Medroxyprogesterone; Menopause, Premature; Paroxetine; Prostatic Neoplasms; Quality of Life; Selective Serotonin Reuptake Inhibitors; Survivors; Treatment Outcome; Venlafaxine Hydrochloride	2004
Noradrenergic and serotonergic modulation to treat vasomotor symptoms. The journal of the British Menopause Society, 2006, Volume: 12, Issue:1 Topics: Citalopram; Cyclohexanols; Female; Fluoxetine; Hot Flashes; Humans; Menopause; Mianserin; Mirtazapine; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Trazodone; Venlafaxine Hydrochloride	2006
Managing hot flashes in men being treated for prostate cancer. Geriatrics, 2007, Volume: 62, Issue:11 Topics: Androgen Antagonists; Antineoplastic Agents; Combined Modality Therapy; Complementary Therapies; Cyclohexanols; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Male; Megestrol Acetate; Orchiectomy; Prostatic Neoplasms; Testosterone; Venlafaxine Hydrochloride	2007
Beyond estrogen: new alternatives for the management of hot flashes. South Dakota journal of medicine, 2002, Volume: 55, Issue:1 Topics: Cyclohexanols; Estrogens; Estrogens, Non-Steroidal; Female; Hot Flashes; Humans; Isoflavones; Middle Aged; Phytoestrogens; Placebos; Plant Preparations; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2002

Trials

29 trial(s) available for cyclohexanol and Hot Flashes

Article	Year
Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Nov-10, Volume: 31, Issue:32 Topics: Aged; Aged, 80 and over; Androgen Antagonists; Cyclohexanols; Double-Blind Method; Hot Flashes; Humans; Male; Middle Aged; Prostatic Neoplasms; Quality of Life; Selective Serotonin Reuptake Inhibitors; Soybean Proteins; Venlafaxine Hydrochloride	2013
Venlafaxine alters microvascular perfusion, [¹²³I]-beta-CIT binding and BDI scores in flushing postmenopausal women. Maturitas, 2014, Volume: 77, Issue:3 Topics: Aged; Brain; Cyclohexanols; Endothelium, Vascular; Female; Hot Flashes; Humans; Microvessels; Middle Aged; Postmenopause; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Skin; Tomography, Emission-Computed, Single-Photon; Venlafaxine Hydrochloride	2014
Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial. JAMA internal medicine, 2014, Volume: 174, Issue:7 Topics: Adult; Cyclohexanols; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Patient Satisfaction; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2014
Sexual function in women on estradiol or venlafaxine for hot flushes: a randomized controlled trial. Obstetrics and gynecology, 2014, Volume: 124, Issue:2 Pt 1 Topics: Adult; Cyclohexanols; Double-Blind Method; Dyspareunia; Estradiol; Estrogens; Female; Hot Flashes; Humans; Middle Aged; Orgasm; Perimenopause; Postmenopause; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Vagina; Venlafaxine Hydrochloride	2014
Effects of estradiol and venlafaxine on insomnia symptoms and sleep quality in women with hot flashes. Sleep, 2015, Jan-01, Volume: 38, Issue:1 Topics: Cyclohexanols; Double-Blind Method; Estradiol; Estrogens; Female; Hot Flashes; Humans; Menopause; Middle Aged; Perimenopause; Sleep; Sleep Initiation and Maintenance Disorders; Venlafaxine Hydrochloride	2015
Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms. Obstetrics and gynecology, 2015, Volume: 126, Issue:2 Topics: Citalopram; Cyclohexanols; Dietary Supplements; Double-Blind Method; Estradiol; Estrogens; Exercise; Fatty Acids, Omega-3; Female; Hot Flashes; Humans; Middle Aged; Monitoring, Physiologic; Outcome Assessment, Health Care; Perimenopause; Postmenopause; Selective Serotonin Reuptake Inhibitors; Vasomotor System; Venlafaxine Hydrochloride; Yoga	2015
Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study. Breast cancer research and treatment, 2009, Volume: 115, Issue:3 Topics: Adrenergic alpha-Agonists; Adult; Breast Neoplasms; Clonidine; Cross-Over Studies; Cyclohexanols; Double-Blind Method; Female; Hot Flashes; Humans; Middle Aged; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Treatment Outcome; Venlafaxine Hydrochloride	2009
A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause. American journal of obstetrics and gynecology, 2009, Volume: 200, Issue:2 Topics: Adult; Aged; Cyclohexanols; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hot Flashes; Humans; Middle Aged; Neurotransmitter Uptake Inhibitors; Postmenopause; Treatment Outcome; United States; Vasomotor System	2009
Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safety. American journal of obstetrics and gynecology, 2009, Volume: 200, Issue:3 Topics: Cyclohexanols; Desvenlafaxine Succinate; Female; Hot Flashes; Humans; Menopause; Middle Aged; Neurotransmitter Uptake Inhibitors; Placebos; Severity of Illness Index; Treatment Outcome; Vasomotor System	2009
Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial. The Lancet. Oncology, 2010, Volume: 11, Issue:2 Topics: Adenocarcinoma; Androgen Antagonists; Autonomic Agents; Cyclohexanols; Cyproterone Acetate; Double-Blind Method; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Male; Medroxyprogesterone Acetate; Prospective Studies; Prostatic Neoplasms; Treatment Outcome; Venlafaxine Hydrochloride	2010
Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: a randomized controlled trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Feb-01, Volume: 28, Issue:4 Topics: Acupuncture Therapy; Adult; Aged; Analgesics; Antidepressive Agents, Second-Generation; Breast Neoplasms; Cyclohexanols; Estrogen Replacement Therapy; Female; Follow-Up Studies; Hot Flashes; Humans; Middle Aged; Postmenopause; Prognosis; Quality of Life; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Treatment Outcome; Venlafaxine Hydrochloride	2010
Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Dec-10, Volume: 28, Issue:35 Topics: Amines; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Breast Neoplasms; Cross-Over Studies; Cyclohexanecarboxylic Acids; Cyclohexanols; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Middle Aged; Patient Preference; Surveys and Questionnaires; Survivors; Treatment Outcome; Venlafaxine Hydrochloride	2010
Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Oct-10, Volume: 29, Issue:29 Topics: Adult; Aged; Analgesics; Breast Neoplasms; Clonidine; Cyclohexanols; Double-Blind Method; Female; Hot Flashes; Humans; Middle Aged; Placebos; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2011
The effect of dose titration and dose tapering on the tolerability of desvenlafaxine in women with vasomotor symptoms associated with menopause. Journal of women's health (2002), 2012, Volume: 21, Issue:2 Topics: Aged; Cyclohexanols; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hot Flashes; Humans; Middle Aged; Nausea; Neurotransmitter Uptake Inhibitors; Patient Satisfaction; Postmenopause; Vasomotor System	2012
Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms. Climacteric : the journal of the International Menopause Society, 2012, Volume: 15, Issue:1 Topics: Adult; Aged; Cyclohexanols; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Estrogen Receptor Modulators; Female; Follicle Stimulating Hormone; Hot Flashes; Humans; Menopause; Middle Aged; Neurotransmitter Uptake Inhibitors; Norpregnenes; Treatment Outcome; Vasomotor System	2012
Effect of desvenlafaxine on mood and climacteric symptoms in menopausal women with moderate to severe vasomotor symptoms. Climacteric : the journal of the International Menopause Society, 2013, Volume: 16, Issue:1 Topics: Adult; Affective Symptoms; Aged; Anger; Anxiety; Back Pain; Confusion; Cyclohexanols; Depression; Desvenlafaxine Succinate; Double-Blind Method; Fatigue; Female; Hot Flashes; Humans; Hyperhidrosis; Irritable Mood; Menopause; Middle Aged; Neurotransmitter Uptake Inhibitors; Patient Satisfaction; Sexual Behavior; Surveys and Questionnaires	2013
Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial. Menopause (New York, N.Y.), 2013, Volume: 20, Issue:1 Topics: Aged; Antidepressive Agents; Cyclohexanols; Desvenlafaxine Succinate; Double-Blind Method; Female; Hot Flashes; Humans; Menopause; Middle Aged; Placebos; Postmenopause; Treatment Outcome	2013
Maintenance of the efficacy of desvenlafaxine in menopausal vasomotor symptoms: a 1-year randomized controlled trial. Menopause (New York, N.Y.), 2013, Volume: 20, Issue:1 Topics: Aged; Antidepressive Agents; Cyclohexanols; Desvenlafaxine Succinate; Double-Blind Method; Female; Hot Flashes; Humans; Menopause; Middle Aged; Placebos; Postmenopause; Treatment Outcome	2013
Cardiovascular, cerebrovascular, and hepatic safety of desvenlafaxine for 1 year in women with vasomotor symptoms associated with menopause. Menopause (New York, N.Y.), 2013, Volume: 20, Issue:1 Topics: Aged; Cardiovascular Diseases; Cerebrovascular Disorders; Chemical and Drug Induced Liver Injury; Cyclohexanols; Desvenlafaxine Succinate; Double-Blind Method; Female; Hot Flashes; Humans; Menopause; Middle Aged; Placebos; Risk Factors; Treatment Outcome	2013
Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial. Obstetrics and gynecology, 2005, Volume: 105, Issue:1 Topics: Antidepressive Agents; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Female; Hot Flashes; Humans; Libido; Postmenopause; Quality of Life; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2005
Evaluation of low-dose venlafaxine hydrochloride for the therapy of hot flushes in breast cancer survivors. Maturitas, 2005, Sep-16, Volume: 52, Issue:1 Topics: Adolescent; Adult; Breast Neoplasms; Cyclohexanols; Drug Administration Schedule; Female; Hot Flashes; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Survivors; Treatment Outcome; Venlafaxine Hydrochloride	2005
Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine. Journal of palliative medicine, 2005, Volume: 8, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Citalopram; Cyclohexanols; Female; Hot Flashes; Humans; Middle Aged; Pilot Projects; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Failure; Venlafaxine Hydrochloride	2005
Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Mar-20, Volume: 24, Issue:9 Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Cyclohexanols; Drug Therapy, Combination; Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2006
Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer. The oncologist, 2007, Volume: 12, Issue:1 Topics: Adult; Breast Neoplasms; Cyclohexanols; Disease-Free Survival; Double-Blind Method; Female; Hot Flashes; Humans; Placebos; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2007
Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study. Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:4 Topics: Adult; Aged; Breast Neoplasms; Clonidine; Cyclohexanols; Double-Blind Method; Female; Hot Flashes; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2007
Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial. Obstetrics and gynecology, 2008, Volume: 111, Issue:1 Topics: Adult; Aged; Cyclohexanols; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hot Flashes; Humans; Menopause; Middle Aged; Neurotransmitter Uptake Inhibitors; Treatment Outcome	2008
Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:7 Topics: Adult; Antidepressive Agents, Second-Generation; Antineoplastic Agents; Cyclohexanols; Female; Hot Flashes; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride	1998
Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer. The Journal of urology, 1999, Volume: 162, Issue:1 Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antidepressive Agents, Second-Generation; Cyclohexanols; Hot Flashes; Humans; Male; Middle Aged; Pilot Projects; Prostatic Neoplasms; Severity of Illness Index; Venlafaxine Hydrochloride	1999
Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet (London, England), 2000, Dec-16, Volume: 356, Issue:9247 Topics: Antidepressive Agents, Second-Generation; Breast Neoplasms; Cyclohexanols; Double-Blind Method; Female; Hot Flashes; Humans; Venlafaxine Hydrochloride	2000

Other Studies

22 other study(ies) available for cyclohexanol and Hot Flashes

Article	Year
Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network. Menopause (New York, N.Y.), 2014, Volume: 21, Issue:1 Topics: Biomedical Research; Citalopram; Cyclohexanols; Dietary Supplements; Double-Blind Method; Estradiol; Estrogens; Exercise Therapy; Fatty Acids, Omega-3; Female; Hot Flashes; Humans; Menopause; Outcome Assessment, Health Care; Patient Selection; Placebos; Quality Control; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors; Statistics as Topic; Sweating; Time Factors; Venlafaxine Hydrochloride; Yoga	2014
Concern about the use of venlafaxine to treat vasomotor symptoms. JAMA internal medicine, 2015, Volume: 175, Issue:4 Topics: Cyclohexanols; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Selective Serotonin Reuptake Inhibitors	2015
Concern about the use of venlafaxine to treat vasomotor symptoms--reply. JAMA internal medicine, 2015, Volume: 175, Issue:4 Topics: Cyclohexanols; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Selective Serotonin Reuptake Inhibitors	2015
Menopausal symptoms following tamoxifen treatment for breast cancer. Oncology (Williston Park, N.Y.), 2008, Volume: 22, Issue:4 Suppl Nu Topics: Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclohexanols; Female; Hot Flashes; Humans; Menopause; Middle Aged; Relaxation Therapy; Tamoxifen; Venlafaxine Hydrochloride	2008
Desvenlafaxine: application withdrawal. Desvenlafaxine: withdrawal of marketing application for depression also. Prescrire international, 2009, Volume: 18, Issue:103 Topics: Antidepressive Agents; Cyclohexanols; Depression; Depressive Disorder; Desvenlafaxine Succinate; Europe; Hot Flashes; Humans; Investigational New Drug Application; Marketing of Health Services; Neurotransmitter Uptake Inhibitors; Postmenopause; United States	2009
Desvenlafaxine: a therapeutic option for treatment of menopausal hot flashes. Maturitas, 2010, Volume: 66, Issue:1 Topics: Cyclohexanols; Desvenlafaxine Succinate; Female; Hot Flashes; Humans; Menopause; Selective Serotonin Reuptake Inhibitors	2010
Conventional and complementary therapies: a tale of two research standards? Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Apr-20, Volume: 28, Issue:12 Topics: Acupuncture Therapy; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Complementary Therapies; Cyclohexanols; Deoxycytidine; Dietary Supplements; Evidence-Based Medicine; Gemcitabine; Hot Flashes; Humans; Neoplasms; Peptide Hydrolases; Risk Assessment; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride	2010
Teaching case: menopausal migraine. Headache, 2010, Volume: 50, Issue:2 Topics: Amines; Cyclohexanecarboxylic Acids; Cyclohexanols; Female; Fructose; Gabapentin; gamma-Aminobutyric Acid; Gonadal Steroid Hormones; Herbal Medicine; Hot Flashes; Humans; Menstrual Cycle; Menstruation Disturbances; Middle Aged; Migraine Disorders; Postmenopause; Topiramate; Venlafaxine Hydrochloride	2010
The multidisciplinary management of menopausal symptoms after breast cancer: a unique model of care. Menopause (New York, N.Y.), 2010, Volume: 17, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care Facilities; Amines; Anti-Anxiety Agents; Breast Neoplasms; Clonidine; Cyclohexanecarboxylic Acids; Cyclohexanols; Fatigue; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Libido; Menopause; Middle Aged; Patient Care Team; Patient Education as Topic; Patient Satisfaction; Patient-Centered Care; Practice Guidelines as Topic; Referral and Consultation; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Sweating; Sympatholytics; Venlafaxine Hydrochloride; Vitamin E; Vitamins	2010
Nonestrogenic management of hot flashes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Oct-10, Volume: 29, Issue:29 Topics: Breast Neoplasms; Clonidine; Cyclohexanols; Female; Hot Flashes; Humans; Venlafaxine Hydrochloride	2011
Endpoints of drug discovery for menopausal vasomotor symptoms: interpretation of data from a proxy of disease. Menopause (New York, N.Y.), 2012, Volume: 19, Issue:8 Topics: Acetamides; Amines; Animals; Body Temperature Regulation; Cyclohexanecarboxylic Acids; Cyclohexanols; Disease Models, Animal; Diurnal Enuresis; Drug Discovery; Estradiol; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Hypnotics and Sedatives; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Skin Temperature; Venlafaxine Hydrochloride	2012
Differences in clinician understanding and management of early menopause after breast cancer. Climacteric : the journal of the International Menopause Society, 2013, Volume: 16, Issue:4 Topics: Anxiety; Australia; Breast Neoplasms; Cross-Sectional Studies; Cyclohexanols; Depression; Endocrinology; Exercise; Female; Follicle Stimulating Hormone; General Practitioners; General Surgery; Gynecology; Hot Flashes; Humans; Life Style; Medical Oncology; Menopause, Premature; Practice Patterns, Physicians'; Surveys and Questionnaires; Venlafaxine Hydrochloride	2013
Treatment for hot flushes in women receiving tamoxifen. The Medical journal of Australia, 2002, Sep-02, Volume: 177, Issue:5 Topics: Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Cyclohexanols; Female; Hot Flashes; Humans; Megestrol Acetate; Middle Aged; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Venlafaxine Hydrochloride	2002
Treating hot flashes with drugs: an update. Harvard women's health watch, 2002, Volume: 9, Issue:12 Topics: Acetates; Amines; Anticonvulsants; Antidepressive Agents, Second-Generation; Antihypertensive Agents; Clonidine; Cyclohexanecarboxylic Acids; Cyclohexanols; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Venlafaxine Hydrochloride	2002
Venlafaxine hydrochloride for the treatment of hot flashes. The Annals of pharmacotherapy, 2003, Volume: 37, Issue:11 Topics: Clinical Trials as Topic; Cyclohexanols; Female; Hot Flashes; Humans; Male; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2003
Clinical experience with venlafaxine in the treatment of hot flushes in women with a history of breast cancer. The Netherlands journal of medicine, 2005, Volume: 63, Issue:5 Topics: Adult; Aged; Breast Neoplasms; Cyclohexanols; Female; Follow-Up Studies; Hot Flashes; Humans; Middle Aged; Retrospective Studies; Treatment Outcome; Venlafaxine Hydrochloride	2005
Menopausal symptoms after cessation of hormone replacement therapy. Maturitas, 2006, Feb-20, Volume: 53, Issue:3 Topics: Administration, Topical; Aged; Attitude to Health; Chi-Square Distribution; Complementary Therapies; Cyclohexanols; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Middle Aged; Postmenopause; Prevalence; Retrospective Studies; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2006
Hepatitis associated with low-dose venlafaxine for postmenopausal vasomotor symptoms. The Annals of pharmacotherapy, 2006, Volume: 40, Issue:2 Topics: Chemical and Drug Induced Liver Injury; Cyclohexanols; Dose-Response Relationship, Drug; Female; Hot Flashes; Humans; Liver Function Tests; Middle Aged; Postmenopause; Venlafaxine Hydrochloride	2006
Nonhormonal agents show promise against hot flashes. Journal of the National Cancer Institute, 2000, Jul-19, Volume: 92, Issue:14 Topics: Antidepressive Agents, Second-Generation; Antihypertensive Agents; Clonidine; Contraindications; Controlled Clinical Trials as Topic; Cyclohexanols; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Male; Menopause; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride	2000
Venlafaxine for hot flushes. Lancet (London, England), 2000, Dec-16, Volume: 356, Issue:9247 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Female; Hot Flashes; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2000
Breast cancer and hot flashes. Options for relief. Mayo Clinic health letter (English ed.), 2001, Volume: 19, Issue:3 Topics: Breast Neoplasms; Cyclohexanols; Female; Hot Flashes; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2001
Flushing in a menopausal woman taking venlafaxine. The American journal of psychiatry, 2001, Volume: 158, Issue:8 Topics: Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Estrogens, Conjugated (USP); Female; Flushing; Hot Flashes; Humans; Menopause; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2001